Fighting throat cancer with T cells.
Full text not available from this repository.| Item Type: | Article |
|---|---|
| Status: | Published |
| Journal or Publication Title: | Media Release |
| Date: | 12 June 2020 |
| Subjects: | |
| Divisions: | Human Viral and Cancer Immunology |
| Depositing User: | General Admin |
| Date Deposited: | 07 Jul 2020 10:51 |
| Abstract: | Research led by the Centenary Institute has discovered that immune cells accumulating within the tumour environment, called tumour-resident T cells, are a critical determinant in survival rates of patients suffering from throat cancer. Reported in the prestigious ‘Journal for ImmunoTherapy of Cancer’, the research suggests that strategies aiming to boost these T-cells at tumour sites could be beneficial to patients. |
| Creators: | Creators Email Crawshaw, Tony UNSPECIFIED |
| Last Modified: | 14 Jul 2020 07:09 |
| URI: | https://eprints.centenary.org.au/id/eprint/3 |
Actions (login required)
 |
View Item |
